Movano Current Ratio 2020-2025 | MOVE
Movano current ratio from 2020 to 2025. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
| Movano Current Ratio Historical Data | |||
|---|---|---|---|
| Date | Current Assets | Current Liabilities | Current Ratio |
| 2025-09-30 | $0.01B | $0.01B | 0.70 |
| 2025-06-30 | $0.01B | $0.00B | 1.35 |
| 2025-03-31 | $0.01B | $0.00B | 1.70 |
| 2024-12-31 | $0.01B | $0.00B | 3.02 |
| 2024-09-30 | $0.01B | $0.00B | 3.31 |
| 2024-06-30 | $0.02B | $0.00B | 5.76 |
| 2024-03-31 | $0.00B | $0.01B | 0.68 |
| 2023-12-31 | $0.01B | $0.01B | 1.45 |
| 2023-09-30 | $0.01B | $0.01B | 1.66 |
| 2023-06-30 | $0.02B | $0.01B | 3.53 |
| 2023-03-31 | $0.02B | $0.01B | 2.85 |
| 2022-12-31 | $0.01B | $0.01B | 2.34 |
| 2022-09-30 | $0.02B | $0.00B | 4.14 |
| 2022-06-30 | $0.02B | $0.00B | 6.78 |
| 2022-03-31 | $0.03B | $0.00B | 10.74 |
| 2021-12-31 | $0.04B | $0.00B | 10.89 |
| 2021-09-30 | $0.04B | $0.00B | 14.70 |
| 2021-06-30 | $0.05B | $0.00B | 25.51 |
| 2021-03-31 | $0.05B | $0.00B | 29.40 |
| 2020-12-31 | $0.01B | $0.00B | 5.95 |
| 2020-09-30 | $0.00B | 0.00 | |
| 2020-06-30 | $0.00B | 0.00 | |
| 2020-03-31 | $0.00B | 0.00 | |
| 2019-12-31 | $0.01B | $0.00B | 5.26 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.006B | $0.001B |
| Movano Inc. is a health technology company. It engages in designing devices which empower individuals to optimize their health in order to prevent and better manage chronic diseases. Movano Inc. is based in PLEASANTON, CA. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $36.527B | 42.25 |
| Tempus AI (TEM) | United States | $12.512B | 0.00 |
| Doximity (DOCS) | United States | $7.768B | 31.98 |
| Hims & Hers Health (HIMS) | United States | $7.144B | 58.11 |
| IRHYTHM HLDGS (IRTC) | United States | $5.386B | 0.00 |
| Hinge Health (HNGE) | United States | $3.411B | 0.00 |
| Heartflow (HTFL) | United States | $3.165B | 0.00 |
| Privia Health (PRVA) | United States | $2.868B | 179.38 |
| Inspire Medical Systems (INSP) | United States | $2.680B | 44.34 |
| 10x Genomics (TXG) | United States | $2.597B | 0.00 |
| Omnicell (OMCL) | United States | $2.267B | 46.35 |
| Azenta (AZTA) | United States | $1.840B | 75.47 |
| Enovis (ENOV) | United States | $1.371B | 7.20 |
| Clover Health Investments (CLOV) | United States | $1.312B | 0.00 |
| Schrodinger (SDGR) | United States | $1.237B | 0.00 |
| Butterfly Network (BFLY) | United States | $1.051B | 0.00 |
| Phreesia (PHR) | United States | $0.988B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.868B | 0.00 |
| Talkspace (TALK) | United States | $0.656B | 132.00 |
| Standard BioTools (LAB) | United States | $0.600B | 0.00 |
| Claritev (CTEV) | United States | $0.503B | 0.00 |
| Evolent Health (EVH) | United States | $0.421B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.368B | 0.00 |
| Carlsmed (CARL) | United States | $0.334B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.334B | 0.00 |
| Senseonics Holdings (SENS) | United States | $0.317B | 0.00 |
| TruBridge (TBRG) | United States | $0.311B | 14.28 |
| CapsoVision (CV) | United States | $0.292B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.255B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.190B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.182B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.171B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.163B | 0.00 |
| CareCloud (CCLD) | United States | $0.123B | 6.74 |
| Outset Medical (OM) | United States | $0.096B | 0.00 |
| American Well (AMWL) | United States | $0.077B | 0.00 |
| Pulmonx (LUNG) | United States | $0.073B | 0.00 |
| HeartBeam (BEAT) | United States | $0.072B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.070B | 0.00 |
| NetraMark Holdings (AINMF) | Canada | $0.067B | 0.00 |
| 111 (YI) | China | $0.049B | 0.00 |
| Precipio (PRPO) | United States | $0.041B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.038B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.023B | 0.00 |
| Lunai Bioworks (LNAI) | United States | $0.022B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.020B | 0.00 |
| Zhongchao (ZCMD) | China | $0.013B | 0.00 |
| HeartSciences (HSCS) | United States | $0.010B | 0.00 |
| PROFUSA (PFSA) | United States | $0.009B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.008B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.008B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.003B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.001B | 0.00 |